Disclosures for "The Impact of Antidopaminergic Medication on Longitudinal Clinical Progression in Huntington Disease"
-
Dr. Geva has nothing to disclose.
-
Dr. Hand has received personal compensation for serving as an employee of Prilenia Therapeutics. Dr. Hand has received personal compensation for serving as an employee of Apic Bio, Inc.
-
Paul Goldberg has received personal compensation for serving as an employee of Prilenia. Paul Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Paul Goldberg has stock in Prilenia.
-